The current research & development by business enterprise, pharmaceutical industry in constant ppp $ in Italy is 979.09 million, which has increased by 11.61 million (1.2%) since 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Italy
No matching regions
Similar regions to Italy
Business R&D pharmaceutical in constant PPP $
More indicators for Italy
Government R&D in security as % of government support
0.51%
+0.07%
(2021)
Higher-education-finacing R&D financed by general university in local currency
41,060.76M
+1,583.99M
(2021)
R&D financed by rest of the world in local currency
22,883.16M
-5,358.99M
(2021)
Government R&D financed by rest of the world in local currency
2,372.94M
-83.30M
(2021)
Business R&D financed by rest of the world in local currency
14,853.07M
-5,054.20M
(2021)
Non-profit R&D growth rate
0.64%
-0.01%
(2022)
Italy Business R&D pharmaceutical in constant PPP $ between 1991 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 979.09M | +11.61M |
| 2020 | 967.48M | +112.50M |
| 2019 | 854.98M | +52.96M |
| 2018 | 802.02M | +5.80M |
| 2017 | 796.22M | +6.93M |
| 2016 | 789.29M | +59.90M |
| 2015 | 729.40M | +30.34M |
| 2014 | 699.06M | -51.44M |
| 2013 | 750.50M | -54.08M |
| 2012 | 804.58M | -14.57M |
| 2011 | 819.15M | +17.34M |
| 2010 | 801.81M | +30.75M |
| 2009 | 771.06M | +65.53M |
| 2008 | 705.53M | +71.24M |
| 2007 | 634.28M | +110.10M |
| 2006 | 524.18M | -84.88M |
| 2005 | 609.06M | +25.02M |
| 2004 | 584.04M | -204.58M |
| 2003 | 788.62M | -30.18M |
| 2002 | 818.80M | -81.00M |
| 2001 | 899.81M | -32.14M |
| 2000 | 931.94M | +28.80M |
| 1999 | 903.15M | -16.41M |
| 1998 | 919.56M | +62.24M |
| 1997 | 857.32M | -51.00M |
| 1996 | 908.32M | -59.13M |
| 1995 | 967.45M | -40.14M |
| 1994 | 1,007.59M | -128.31M |
| 1993 | 1,135.91M | -199.08M |
| 1992 | 1,334.98M | +2.36M |
| 1991 | 1,332.62M |